ACKERMANN CHRISTINA 4
4 · Verona Pharma plc · Filed Sep 5, 2023
Insider Transaction Report
Form 4
ACKERMANN CHRISTINA
Director
Transactions
- Award
Share Options (Right to Buy)
2023-09-01+144,000→ 144,000 totalExercise: $2.43Exp: 2033-08-31→ Ordinary Shares (144,000 underlying)
Footnotes (2)
- [F1]The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]The option vests and becomes exercisable as to one-third of the underlying options on September 1, 2024 and the remainder in eight equal quarterly installments over the two years thereafter.